{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:41Z","timestamp":1707524921038},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,12]]},"DOI":"10.7759\/cureus.33713","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T20:37:39Z","timestamp":1673555859000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Analysis of Topiramate and Drug Reaction With Eosinophilia and Systemic Symptoms"],"prefix":"10.7759","author":[{"given":"Ameila","family":"Thoms","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrina","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"De La Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven S","family":"Smugar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107844","article-title":"Severe cutaneous adverse reaction associated with antiseizure medications: diagnosis, management, and prevention","volume":"117","author":"Brandt C","year":"2021","unstructured":"Brandt C, McGuire L, Uetrecht J. Severe cutaneous adverse reaction associated with antiseizure medications: diagnosis, management, and prevention. Epilepsy Behav. 2021, 117:107844. 10.1016\/j.yebeh.2021.107844","journal-title":"Epilepsy Behav"},{"key":"ref2","unstructured":"Topamax United States product information. (2021). Accessed. June 2, 2022: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16751","article-title":"Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: a nationwide study using health claims data in Korea","volume":"62","author":"Chung SJ","year":"2021","unstructured":"Chung SJ, Ahn KM, Oh JH, Shim JS, Park HW. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: a nationwide study using health claims data in Korea. Epilepsia. 2021, 62:250-7. 10.1111\/epi.16751","journal-title":"Epilepsia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e17","article-title":"Adverse skin reactions with antiepileptic drugs using Korea Adverse Event Reporting System Database, 2008-2017","volume":"35","author":"Kim HK","year":"2020","unstructured":"Kim HK, Kim DY, Bae EK, Kim DW. Adverse skin reactions with antiepileptic drugs using Korea Adverse Event Reporting System Database, 2008-2017. J Korean Med Sci. 2020, 35:e17. 10.3346\/jkms.2020.35.e17","journal-title":"J Korean Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun SH","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156:609-11. 10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"key":"ref7","unstructured":"European Medicines Agency EudraVigilance user manual. (2021). Accessed. 2022: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/eudravigilance-user-manual-marketing-authorisa...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000477742","article-title":"Acneiform rash caused by an unlikely drug: topiramate","volume":"4","author":"Bello-Hern\u00e1ndez Y","year":"2018","unstructured":"Bello-Hern\u00e1ndez Y, Espinoza-Hern\u00e1ndez J, Moreno-Couti\u00f1o G. Acneiform rash caused by an unlikely drug: topiramate. Skin Appendage Disord. 2018, 4:25-8. 10.1159\/000477742","journal-title":"Skin Appendage Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-015-0526-4","article-title":"What is this rash?","volume":"12","author":"Gleeson TP","year":"2016","unstructured":"Gleeson TP, Griswold MK, Broach J, Babu KM. What is this rash?. J Med Toxicol. 2016, 12:199-200. 10.1007\/s13181-015-0526-4","journal-title":"J Med Toxicol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/08830738050200022001","article-title":"Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report","volume":"20","author":"Cheung E","year":"2005","unstructured":"Cheung E, Wong V, Fung CW. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol. 2005, 20:157-60. 10.1177\/08830738050200022001","journal-title":"J Child Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13462","article-title":"Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits","volume":"82","author":"Santiago LG","year":"2020","unstructured":"Santiago LG, Morgado FJ, Baptista MS, Gon\u00e7alo M. Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits. Contact Dermatitis. 2020, 82:290-6. 10.1111\/cod.13462","journal-title":"Contact Dermatitis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000692","article-title":"CD30 positive lymphomatoid angiocentric drug reactions: characterization of a series of 20 cases","volume":"39","author":"Magro CM","year":"2017","unstructured":"Magro CM, Olson LC, Nguyen GH, de Feraudy SM. CD30 positive lymphomatoid angiocentric drug reactions: characterization of a series of 20 cases. Am J Dermatopathol. 2017, 39:508-17. 10.1097\/DAD.0000000000000692","journal-title":"Am J Dermatopathol"},{"key":"ref13","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) and antiepileptic drugs (AEDS): a case-non case approach from European pharmacovigilance database","volume":"38","author":"Renda F MP","year":"2015","unstructured":"Renda F MP, Di Girolamo M, Catalano L, Bertini Malgarini R, Pimpinella G. Drug reaction with eosinophilia and systemic symptoms (DRESS) and antiepileptic drugs (AEDS): a case-non case approach from European pharmacovigilance database. 2015, 38:1001."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1005-8","article-title":"Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs","volume":"67","author":"Pereira de Silva N","year":"2011","unstructured":"Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol. 2011, 67:463-70. 10.1007\/s00228-011-1005-8","journal-title":"Eur J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago F","year":"2010","unstructured":"Santiago F, Gon\u00e7alo M, Vieira R, Coelho S, Figueiredo A. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis. 2010, 62:47-53. 10.1111\/j.1600-0536.2009.01659.x","journal-title":"Contact Dermatitis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0009922818787321","article-title":"DRESS following FIRES: a clinical conundrum","volume":"57","author":"Dahl AR","year":"2018","unstructured":"Dahl AR, Knoebel EE, Lloyd RM. DRESS following FIRES: a clinical conundrum. Clin Pediatr (Phila). 2018, 57:1479-82. 10.1177\/0009922818787321","journal-title":"Clin Pediatr (Phila)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung WH","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, et al.. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004, 428:486. 10.1038\/428486a","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions","volume":"93","author":"Mullan KA","year":"2019","unstructured":"Mullan KA, Anderson A, Illing PT, Kwan P, Purcell AW, Mifsud NA. HLA-associated antiepileptic drug-induced cutaneous adverse reactions. HLA. 2019, 93:417-35. 10.1111\/tan.13530","journal-title":"HLA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013, 68:693. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson AR","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract. 2019, 7:633-40. 10.1016\/j.jaip.2018.08.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell L","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006, 29:385-96. 10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129832-a-comprehensive-analysis-of-topiramate-and-drug-reaction-with-eosinophilia-and-systemic-symptoms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:37Z","timestamp":1707508537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129832-a-comprehensive-analysis-of-topiramate-and-drug-reaction-with-eosinophilia-and-systemic-symptoms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.33713","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}